Outlook Therapeutics Inc (NASDAQ:OTLK)

2.23
BATS BZX Real-Time Price
As of 2:17pm ET
 -0.23 / -9.35%
Today’s Change
0.58
Today|||52-Week Range
4.26
+71.54%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +124.22% increase from the last price of 2.23.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Outlook Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$325.0K
Reporting Date
Aug 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.22%
 
 
 
 
 
 
Growthannually 36.17%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.